Four platforms, one pipeline.
They were built to hand work to each other: one laboratory, one quality framework, and data that carries from stage to stage.

What each platform takes in and gives back.
Works withMesenchymal stem cell and plant sources
DeliversPurified, characterised and cargo-loaded vesicles
HNOVAWorks withBioactives, nucleic acids and proteins
DeliversStable liposomal and topical formulations
STEMZAWorks withDefined tissue sources
DeliversExpanded, characterised MSCs and conditioned media
HTWorks withClinical and research samples
DeliversVerified multiplex assays
How the platforms connect.
Cells from one platform feed the next, and because they share a laboratory, a result at one stage is directly usable at the next.
What all four platforms share.
One laboratory
Work moves between platforms without leaving the building.
One quality framework
The same documentation and review applies to every lot.
Common data standards
Results are recorded in a form the next stage can use.
People who move across
Scientists work on more than one platform, so knowledge carries over.
Choose by what you start with.
About the platforms.
Can one programme use more than one platform?
Yes. Many do, and the shared laboratory is designed for that.
Are the platforms offered separately?
Yes. Each can be engaged on its own.
Is any of the output clinical grade?
No. Materials are research grade today, and GMP manufacturing is a planned build-out.
How do the platforms relate to the brands?
HNEV underlies Exomie and HNOVA underlies Lipologics.


